Down 99%, this stock has been crushed by AI and is now a penny share!

Chegg has gone from being a fast-growth tech stock to a penny share trading for less than $1 in the space of four years. Ben McPoland explains why.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Frustrated young white male looking disconsolate while sat on his sofa holding a beer

Image source: Getty Images

The market has recently moved on from all things artificial intelligence (AI), focusing instead on global trade and tariffs. But in the background, the AI revolution continues apace and is disrupting some businesses. One is Chegg (NYSE: CHGG), which was trading for $113 in 2021 but is now priced as a penny share at $0.75.

That’s a shocking four-year decline of 99%!

An example of disruption

Chegg is an education technology company that offers services like textbook rentals, homework help, and study resources. Its customers are mainly college and high school students. 

However, as we know, generative AI bots like ChatGPT now — somewhat controversially — offer free help with homework and essays, undermining Chegg’s value proposition. Basically, students seem to be thinking: ‘why pay for Chegg when AI gives you free answers?’

In 2023, management said: “Since March we saw a significant spike in student interest in ChatGPT. We now believe it’s having an impact on our new customer growth rate.”

Chegg was right. In two years, its subscribers have gone from 5.1m to 3.2m, with revenue falling from $188m to $121m in that time. Worryingly, its cash position has fallen from $281m in Q1 2023 to just $44m at the end of March (and it’s now loss-making).

To try to improve things, the company is drastically cutting costs and exploring being acquired. Perhaps that can salvage some value (the market cap is now just $79m).

It’s also licensing its question-and-answer pairs to language model companies, though that appears to be a double-edged sword to me. Yes, it’s generating revenue by leveraging proprietary education data, but giving AI companies its content could cannibalise the core subscription business.

Today (12 May), Chegg’s management wrote: “We believe the trends impacting our business will worsen before they get better.”

Those “trends” are, of course, mainly declining subscribers due to competition from generative AI.

AI is not a single event

Many people have likened AI to the internet, but it does appear different to me.

While revolutionary, the internet was a one-time platform shift. But AI is not a single watershed moment. Rather, it’s a self-improving force, constantly learning and evolving, perhaps exponentially. 

Consequently, I expect a lot more disruption — and potential opportunities — in the years ahead.

This stock looks in no danger from AI

Of course, there will be some businesses that AI won’t hurt. It should even make them more efficient and profitable. Many of these can be found in the FTSE 100, including miners, global banks, and oil giants.

One UK stock that might be worth considering is AstraZeneca. It’s down 16% since March as investors worry about the Trump administration’s drive to lower drug prices in the US. This is a risk worth mentioning, as the US is AstraZeneca’s largest market.

However, in terms of AI, the technology could actually turbocharge the company’s drug discovery process. Not only that, but AstraZeneca has the wherewithal to really invest in its AI capabilities, unlike most smaller upstarts.

To me, the firm looks more likely to benefit from AI than be threatened by it. With the stock trading at a reasonable 15 times forward earnings, I think it’s worth a look.

Ben McPoland has positions in AstraZeneca Plc. The Motley Fool UK has recommended AstraZeneca Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

10.7% yield! Should investors snap up Taylor Wimpey shares before they go ex-dividend on 2 April?

Harvey Jones is stunned by the double-digit yield available from Taylor Wimpey shares. But the FTSE 250 stock comes with…

Read more »

White female supervisor working at an oil rig
Investing For Beginners

Are investors taking a massive gamble with the Shell share price?

Jon Smith mulls the current state of play in the oil market and explains why he thinks further gains for…

Read more »

Young brown woman delighted with what she sees on her screen
Investing Articles

Stock market correction 2026: a rare chance to scoop up cheap UK shares?

The UK stock market's officially in a correction after a sharp drop in UK share prices, but our writer sees…

Read more »

Investing Articles

How much do you need in an ISA to aim for a £750 monthly second income?

Harvey Jones crunches the numbers to show how investors could aim for a high-and-rising second income from dividend-paying FTSE 100…

Read more »

Investing Articles

£20,000 invested in a Stocks and Shares ISA over the last year is now worth…

With tax season coming to an end, investors will soon have a fresh £20k allowance for their Stocks and Shares…

Read more »

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

Back above 10,000! Is the FTSE 100 index on track again?

The FTSE 100 index has been yo-yoing up and down with the latest news headlines around the oil crisis. Where…

Read more »

Finger clicking a button marked 'Buy' on a keyboard
Investing Articles

Stock market correction: Is there still time to buy UK shares cheap?

Long-term investors can do well to stay calm through stock market corrections, and even crashes, and pick up shares when…

Read more »

Warm summer evening outside waterfront pubs and restaurants at the popular seaside resort town of Weymouth, Dorset.
Investing Articles

2 FTSE 100 blue-chips to consider for a new £20k Stocks and Shares ISA

Ben McPoland highlights a pair of high-quality FTSE 100 stocks that have strong momentum on their side yet are trading…

Read more »